FDA staff said a proposed sleep drug from Merck was effective, but questioned the safety of the product's higher doses. Merck is seeking FDA approval of a drug called suvorexant to treat insomnia. The product will be reviewed Wednesday by an FDA advisory committee.
Next month, iShares, the largest ETF provider by assets, will do something it hasn't done in more than a decade: close one of its 290 ETFs. Experts say that highlights the complications that arise when funds drop out.
John Malone's international cable business, Liberty Global, has put its Chellomedia TV-channel business up for sale. The business could fetch between $800 million and $1 billion.
Dell sent another letter to Carl Icahn and Southeastern Asset Management seeking more information about their takeover proposal, reiterating that it can't engage in talks before determining whether the proposal is credible.
Analysts say it is too close to call the outcome of Tuesday's crucial J.P. Morgan shareholder vote that could result in the separation of the bank's chairman and chief executive positions.
President Obama says you have to work twice as hard if you are black. Do you agree?
General Electric said GE Capital's board approved a $6.5 billion dividend payment to the conglomerate, which reflects 30% of the financial arm's planned 2013 earnings.
Chesapeake Energy tapped Robert Douglas Lawler, a 46-year-old executive at Anadarko Petroleum, to succeed Chesapeake co-founder Aubrey McClendon as CEO of the nation's second-largest natural-gas producer.
A new wave of private firms that cater to clients' every imaginable financial need are increasingly courting the merely wealthy. Here's what they offer.
